CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
A phase Ib trial of pembrolizumab (Pembro) following adoptive cell therapy (ACT) in patients with platinum-resistant ovarian cancer; The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) trial.
Author
Alexandra Maria Easson
Blaise A. Clarke
+18Â more
David Paul Goldstein
Genevieve Bouchard-Fortier
Habeeb Majeed
Jane Cipollone
Josee-Lyne Ethier
Linh T. Nguyen
Luisa Bonilla
Marcus O. Butler
Marjan Rouzbahman
Michael Reedijk
Neesha C. Dhani
Norman Franke
Pamela S Ohashi
Patricia Ann Shaw
Sam Saibil
Sarah Boross-Harmer
Stephanie Lheureux
Taymaa May
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref